- Deloitte and Rady’s Children’s Institute for Genomic Medicine (RCIGM) announced an innovative new project to explore the use of unmanned aircraft systems (UAS) known as drones to deliver genomic samples to the laboratory.- This approach seeks to cut down on ground traffic delays by flying genomic testing specimens to the lab, cutting the time needed to get results back to acutely ill babies and children.- The project is in the planning stages; Deloitte and RCIGM are working in coordination
Read More
Health Data Privacy: Why Eroding Public Trust Harms Medical Research
Scott Kahn, Ph.D, Chief Information Officer at LunaPBC
Using Data Privacy to Empower Health Research
The importance of data security and data privacy policies have recently come under scrutiny due to revelations around Google’s Project Nightingale. The initiative with Ascension, the nation’s largest nonprofit health system, granted Google access to medical records of more than 50 million individuals in 21 states and may hinder the trajectory of health discovery by eroding “consumer”
Read More
Shriners Hospitals for Children Launches New Genomics Institute to Advance Precision Medicine
- Shriners Hospitals for Children establishes new genomics institute to advance precision medicine in partnership with Genome Medical to return actionable genetic findings for pediatric patients. - Genomics Institute at Shriners Hospitals will offer genetic sequencing to patients at its 22 hospitals and outpatient locations in North America and from its international network of outreach clinics.Shriners Hospitals for Children is teaming up with Genome Medical to ensure that pediatric patients
Read More
UIUC, Infosys Form Strategic Partnership to Develop Precision Medicine Solutions
The University of Illinois Urbana-Champaign (UIUC) and Infosys, a provider of next-generation digital services and consulting has formed a strategic partnership to develop precision medicine solutions. As part of the strategic partnership, Infosys becomes a member of the Center for Computational Biotechnology and Genomic Medicine (CCBGM). Precision Medicine Strategic Partnership DetailsThe adoption of precision medicine solutions by healthcare companies has significant benefits, including
Read More
Telegenomics Company Genome Medical Nabs $23M to Bring Genomic Medicine to Everyday Care
Genome Medical, a leading nationwide telegenomics company providing genomic-based medicine, today announced that it has raised $23 million in Series B financing to accelerate the development of its technology and medical services which support patients, physicians and healthcare systems in all 50 states. The Series B round was led by Echo Health Ventures, a strategic collaboration of Cambia Health Solutions and Mosaic Health Solutions with additional new investors LRVHealth, Casdin
Read More
Emedgene Lands $6M to Expand AI-Driven Genomics Interpretation Platform
Emedgene, a Palo Alto, CA-based artificial intelligence (AI) driven genomics interpretation platform, today announced it has raised $6 million in funding led by health-focused OliveTree Ventures. The company plans to utilize the latest round of funding to expand sales operations in the US. Emedgene's Genomics Intelligence Platform OverviewThis rise in genomics-based medicine is putting tremendous pressure on geneticists globally - who must analyze and interpret each test. It is a costly,
Read More
Luna DNA Raises $4M for Community-owned Genomic and Medical Research Database
Luna DNA, the first community-owned genomic and medical research database has raised $4 million in funding from lead investors Illumina Ventures and Arch Venture Partners. Additional investors include UK-based Bridgelink Capital; Seattle-based Hemisphere Ventures; and Dr. Aristides Patrinos, a former leader of the Human Genome Project and current advisor to Luna DNA. The startup plans to use the funds to support the next phase in creating Luna’s research platform and engaging a global community
Read More
3 Major Trends That Will Transform Genomic Medicine
After the Human Genome Project was completed in 2003, early successes in genomic medicine fell short of the initial high expectations. But today, a potent mix of influences—including innovation in biology and technology, market demand and consumerism—is furthering an evolution that crosses industries.
Healthcare providers can now personalize care plans thanks to lower sequencing costs that allow genomic data to be combined with electronic health data. Life sciences companies can develop
Read More
